[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
April 21, 2010

Incorrect Wording and Omitted Language in: Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women With Elevated Risk of Breast Cancer

JAMA. 2010;303(15):1482. doi:10.1001/jama.2010.445

Incorrect Wording and Omitted Language: In the Original Contribution entitled “Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women With Elevated Risk of Breast Cancer,” published in the May 14, 2008, issue of JAMA (2008;299[18]:2151-2163), incorrect wording appeared in 2 tables and 1 figure. The “Targeted” row stub in the “Prior breast ultrasound” subcategory of “Imaging History” of Table 1 on page 2153 should have read “Targeted or other by patient report.” In footnote f on page 2154 of Table 1, the second sentence that read “BRCA-mutation carrier status and prior chest/mediastinal radiation were prioritized over personal history of breast cancer, which was prioritized over prior atypical biopsy result, then risk by Gail or Claus models (lifetime risk prioritized over 5 y risks >2.5% then 1.7% and extremely dense parenchyma, respectively).” should have read “BRCA-mutation carrier status and prior chest/mediastinal radiation were prioritized over personal history of breast cancer, which was prioritized over risk by Gail or Claus models (lifetime risk prioritized over 5 y risks >2.5% then 1.7% and extremely dense parenchyma, respectively), then prior atypical biopsy result.” Footnote symbol g should be added to the end of row stub “ADH, ALH, LCIS, or atypical papilloma.” The corresponding footnote should read: “gA patient originally included in this group for both eligible and analysis sets was receiving chemoprevention therapy: her basis of eligibility is unknown as reported by the site, even though her reported family history yields a lifetime Gail model risk exceeding 25%.” Footnote symbol h should replace g in the row stub “Mutation in BRAC1 or BRAC2 genes” and replace it in the corresponding footnote.

The legend in the a footnote of Figure 1, on page 2155, that read “A Breast Imaging Reporting Data System score of 3 or more was considered a positive test result, a score less than 3, negative” should have read “A Breast Imaging Reporting Data System score greater than 3 was considered a positive test result, a score of 3 or less, negative.”

In Table 5, on page 2160, the row stub “ADH, ALH, LCIS, or atypical papilloma,” should be followed by the footnote symbol d. The corresponding footnote should read: “dA patient originally included in this group for the analysis set was receiving chemoprevention therapy. Her basis of eligibility is unknown as reported by the site, even though her reported family history yields a lifetime Gail model risk exceeding 25%. She did not have cancer.”

×